AMAG PHARMACEUTICALS, INC.: cashflow_financing
| Value | {"amount": -36041000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-06-30 |
| Status | current |
| Entity | AMAG PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:01:04.991802+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/9282704f-850a-498e-9561-8ca7469b8bae
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000792977-19-000121Retrieved: 2026-08-19T08:01:04.991802+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000792977/cashflow-financing/2019-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/9282704f-850a-498e-9561-8ca7469b8bae
History
- no predecessors — first report